Work by Segovia et al. demonstrated that mice with a deficiency for the transmembrane protein 176B (TMEM176B), which inhibits activation of the NLRP3 inflammasome by controlling the cellular Ca2+ flux, efficiently control tumor growth in a caspase 1 and IL-1β-dependent manner. This evidence concerns the gene NLRP3 and neoplasm.